<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02253355</url>
  </required_header>
  <id_info>
    <org_study_id>PINS-006</org_study_id>
    <nct_id>NCT02253355</nct_id>
  </id_info>
  <brief_title>PINS Stimulator System for Patients With Treatment Resistant Depression</brief_title>
  <official_title>PINS Stimulator System for Patients With Treatment Resistant Depression</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beijing Pins Medical Co., Ltd</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Beijing Tiantan Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Beijing Pins Medical Co., Ltd</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluate the effects and safety of Deep Brain Stimulation (DBS) to treat on patients with
      Treatment-Resistant Depression (TRD) and using functional magnetic resonance imaging (fMRI)to
      evaluate the influence of acupuncture on patients, which will be afford objective evidence
      for the mechanism of Acupuncture on depression.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>December 2016</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in the Hamilton Depression Rating Scale-17</measure>
    <time_frame>1, 3, 6 and 12 months of stimulation</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The incidence of all adverse events</measure>
    <time_frame>1, 3, 6 and 12 months of stimulation</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Treatment-Resistant Depression</condition>
  <arm_group>
    <arm_group_label>Deep Brain Stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Stimulation is on</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Stimulation is off</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Deep Brain Stimulation</intervention_name>
    <arm_group_label>Deep Brain Stimulation</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>PINS Stimulator System</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Subject is aged ages 20-70 years

          2. Diagnosed with non-psychotic major depressive disorder, single or recurrent episode by
             DSM-IV-TR criteria

          3. First episode onset before age 45

          4. Current episode &gt; 12 months duration

          5. In the current episode: Documented resistance (i.e. persistence of the major
             depressive episode) to a minimum of 4 adequate depression treatments from at least 3
             different treatment categories (e.g. SSRI's)

          6. SNRI's, TCA's, MAO-inhibitors, Mirtazipine, Nefazodone, Trazodone, Bupropion, lithium
             augmentation, thyroid augmentation, ECT); Adequacy of treatments as defined by a score
             of at least 3 according to the amended Antidepressant Treatment History Form (ATHF)
             criteria

          7. Hamilton Depression Rating Scale (HDRS) of &gt; 20 at 3 separate baseline visits, rated
             by 2 separate psychiatrists, Baseline 2 and Baseline 3 HDRS scores cannot improve â‰¥
             25%

        Exclusion Criteria:

          1. Patients with hearing impairment

          2. Failures of important organs and in severe conditions

          3. Be reluctant or disabled to receive neuropsychological assessments;

          4. Participate in other clinical trial

          5. Has a life expectancy of &lt; 1 year

          6. The investigator and/or enrollment review committee, would preclude participation in
             the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Li Luming, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Tsinghua University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jia Fumin, PhD</last_name>
    <phone>+86 010-59361265</phone>
    <email>pins_medical@163.com</email>
  </overall_contact>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 27, 2014</study_first_submitted>
  <study_first_submitted_qc>September 30, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 1, 2014</study_first_posted>
  <last_update_submitted>October 13, 2016</last_update_submitted>
  <last_update_submitted_qc>October 13, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 14, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Depressive Disorder, Treatment-Resistant</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

